about
Age-related changes in endothelin-1 receptor subtypes in rat heartPacing-induced regional differences in adenosine receptors mRNA expression in a swine model of dilated cardiomyopathy.The role of endothelins and their receptors in heart failure.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.Transcriptional alterations of ET-1 axis and DNA damage in lung tissue of a rat obesity model.Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment.Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure.Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk.Innate inflammation in myocardial perfusion and its implication for heart failure.The role of the adenosinergic system in lung fibrosis.Back to the heart: the protective role of adiponectin.Natriuretic peptide system and the heart.Endothelin system mRNA variation in the heart of Zucker rats: evaluation of a possible balance with natriuretic peptides.Characterization of novel 3'untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide.C-type natriuretic peptide plasma levels are reduced in obese adolescents.Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes.Gene expression of C-type natriuretic peptide and of its specific receptor NPR-B in human leukocytes of healthy and heart failure subjects.Exploring PTX3 expression in Sus scrofa cardiac tissue using RNA sequencing.Plasma C-type natriuretic peptide levels in healthy children.Sequencing and cardiac expression of natriuretic peptide receptors A and C in normal and heart failure pigs.Sequencing and cardiac expression of Apelin in Sus Scrofa.Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa.Increased plasma levels of osteopontin are associated with activation of the renin-aldosterone system and with myocardial and coronary microvascular damage in dilated cardiomyopathy.Chronic long-term nitrate therapy: possible cytogenetic effect in humans?Trimetazidine reduces endogenous free fatty acid oxidation and improves myocardial efficiency in obese humans.C-type natriuretic peptide transcriptomic profiling increases in human leukocytes of patients with chronic heart failure as a function of clinical severity.A possible cardioprotective effect of heat shock proteins during cardiac surgery in pediatric patients.Plasma adrenomedullin relation with Doppler-derived dP/dt in patients with congestive heart failure.High concentration of C-type natriuretic peptide promotes VEGF-dependent vasculogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction.Relation between adiponectin and brain natriuretic peptide in healthy pediatric subjects: from birth through childhood.Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays.Tissue-specific selection of stable reference genes for real-time PCR normalization in an obese rat model.Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction.Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction.Adrenomedullin plasma levels predict left ventricular reverse remodeling after cardiac resynchronization therapy.Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure.Adiponectin plasma levels decrease after surgery in pediatric patients with congenital heart disease.The natriuretic peptide time-course in end-stage heart failure patients supported by left ventricular assist device implant: focus on NT-proCNP.Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure.
P50
Q28575271-210F84F8-61BC-405F-B4B0-E81C7212854EQ31105232-796441CB-74EC-4528-888D-4493C46139DCQ34177863-05DB9978-A373-4FC4-BB4D-E5C0B1DE8C4FQ34979675-1EB5EE01-3801-4012-AC9B-AE0A9EA9E664Q35110780-F1C41A7C-8E14-48A8-8189-44FF047E2680Q35981131-69785A03-A52F-420D-A45F-54C756A1C2AAQ36996413-38311F1F-E3AC-4DC9-B704-76B95C8D8CBEQ37009286-D150DC83-1694-4A32-A637-52FC3E783107Q37800996-009B4DF4-5B22-43F4-914B-A3C9C2B8CBF3Q38133140-5706EBCE-E439-4080-B55D-ACC7B3E81FD6Q38198395-8A2925DA-844B-4B7D-A1DA-A7D45CFF08DCQ38221394-9A6D239E-7E6C-4CC1-B402-28B2B5274EF8Q39161412-4A4067CF-876B-4C24-8346-05335E09A2B0Q39173388-E9540910-C283-43DE-89B8-1041FE12CCD2Q39333991-5FEB85E9-D54F-44E6-8450-E97A766A059FQ39514206-609803CA-99E1-400B-A83B-2342FA7D566BQ39570740-47416C7E-26A5-48C6-B1D5-78F83ABFCA5BQ39682453-82B99859-59AB-4E5A-894C-9C6FD3D908E7Q39685026-83E9E18E-7CD3-418E-81F7-1396CC3197A6Q39899090-4AD7AA75-3350-4660-925A-DB674417901DQ39984802-93F8BEF1-2C9A-4959-8D06-C56B90F40683Q42624175-13F99A1D-4C32-4A32-8B4F-D2772D7980D9Q43209506-04A2E87E-9CD3-43EE-8D43-E200D5290468Q43781547-30235C8F-DFEE-4406-BFDA-9CF86E37F7E6Q44200139-4405E13A-C0DE-43DB-B056-EA329641E83AQ44324877-17E10347-E429-4E24-8624-1AFFC986637AQ44580496-CBA19C32-33FD-426B-96F3-25FA3F5122D1Q45122720-C6C3EC65-AD8B-4B78-8045-3B9A1646C52AQ45331152-37D45539-5182-4EEB-9791-A7E6EE3F956AQ45906055-B83BCD49-8A91-4918-A730-17456C2FD9A2Q46360086-43FE4FC1-A5FE-4BE2-A636-9A92C76B364AQ47440332-701A2D80-4C04-4F91-856B-19A4FCA68FC2Q47918877-635179AE-34B7-47A1-BBC5-827F82390B33Q48030648-DA0C9C98-D53C-4A97-BDA4-657D839D76BBQ48207456-B98EFC6B-C74A-42C0-B08B-712569F8A5C9Q48272156-A4C044B8-92E2-4C32-B34A-459BC7798659Q48278408-E1053324-9981-44EE-A44C-CD162FB0A082Q48430152-4A44AF5B-C4F9-4544-A89E-5EDE4DEC19C8Q48480036-F7C0A8BA-A16D-41DD-978A-58E5AA253556Q48561437-0416ACF9-0ABF-4BA2-84CF-D7E50032F3A7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Silvia Del Ry
@ast
Silvia Del Ry
@en
Silvia Del Ry
@es
Silvia Del Ry
@nl
Silvia Del Ry
@sl
type
label
Silvia Del Ry
@ast
Silvia Del Ry
@en
Silvia Del Ry
@es
Silvia Del Ry
@nl
Silvia Del Ry
@sl
prefLabel
Silvia Del Ry
@ast
Silvia Del Ry
@en
Silvia Del Ry
@es
Silvia Del Ry
@nl
Silvia Del Ry
@sl
P1053
C-1149-2015
P106
P21
P31
P3829
P496
0000-0001-7163-245X